v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Condensed Consolidated Statements of Operations    
Revenue $ 9,651 $ 10,390
Cost of goods sold 1,569 1,497
Gross profit 8,082 8,893
Operating expenses:    
Research and development 3,857 5,903
Sales and marketing 3,428 5,698
General and administrative 5,966 8,526
Depreciation and amortization 1,016 1,061
Total operating expenses 14,267 21,188
Operating loss (6,185) (12,295)
Other income:    
Interest income 1,435 2,034
Total other income 1,435 2,034
Loss before income taxes (4,750) (10,261)
Net loss $ (4,750) $ (10,261)
Basic net loss per share (in dollars per share) $ (0.04) $ (0.1)
Diluted net loss per share (in dollars per share) $ (0.04) $ (0.1)
Weighted-average shares outstanding, basic (In shares) 106,875,087 105,950,480
Weighted-average shares outstanding, diluted (In shares) 106,875,087 105,950,480